Global Insulin Delivery Devices Market Overview
Introduction:
Insulin is a necessary part of the treatment of diabetes, as insulin helps to transfer glucose from the bloodstream into the muscle and fat cells. Further, the insulin cannot be taken as pill or swallowed, because it cannot be broken down by digestive system before it reaches the bloodstream therefore, there are delivery device for injecting insulin into the fatty tissue under the skin. There are various numbers of devices that deliver the insulin in the body such as syringes, insulin pens, jet injectors, and insulin pumps. Furthermore, every patient requires different insulin delivery devices, depending on insulin regimen, and ability to manipulate or operate a particular device, visual ability, or ability to afford a particular device and related supplies, occupation, and daily schedule. Furthermore, the manufactures are also focusing on designing products, which are cost effective for people with diabetes, which is expected to propel the growth of the insulin delivery devices market. For instance, in June 2018 FDA approved Tandem diabetes Care, Inc. automated insulin delivery system with basal-IQ technology. The basal-IQ algorithm predicts where glucose level trends are heading up to 30 mins into the future. The Global Insulin Delivery Devices Market accounted for US$ 16.40 billion in 2020 and is estimated to be US$ 38.62 billion by 2030 and is anticipated to register a CAGR of 8.9%.
Global Insulin Delivery Devices Market Dynamics
Increasing prevalence of diabetes
The insulin deliver devices are gaining significant traction due to the increasing prevalence of diabetes. For instance, According to the Centers for Disease Control and Prevention (CDC), 2014, about 29.1 million people in the U.S. have diabetes with a healthcare burden of around US$ 245 Bn and with an estimated 4.6–9.2% of pregnant women affected by gestational diabetes.
Government initiative
Furthermore, the government initiative to prevent diabetes is also expected to favor the growth of insulin delivery devices market. For instance, the Australian government launched National Diabetes Strategy (2016–20), for an action to prevent diabetes and support the people living with diabetes.
Technological advancement
Moreover, the technological advancement done by the manufacturers to improve the insulin delivery devices are expected to foster the insulin delivery devices market. For instance, in 2014, the Novo Nordisk launched the NovoPen Echo in the U.S., the NovoPen Echo was the first only pen device available in market, with half-unit dosing and memory function that can record the dose and time passed since the last injection.
Global Insulin Delivery Devices Market Segmentation
Global insulin delivery devices market is segmented on the basis of product type, distribution channels, and region. On the basis of product type, the global insulin delivery devices market is segmented into insulin syringes, insulin pens, insulin pumps, and insulin jet injectors. On the basis distribution channel, the target market is categorised into hospital pharmacy, retail pharmacy, and online pharmacies. On the basis of region, global insulin delivery devices market has been segmented into North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. The market in North America is expected to account for major revenue share as compared to that of other regions. This can be attributed to the increasing prevalence of diabetes in the countries of the region. Also, the market in Europe is expected to account for second-highest revenue share in the global market, followed by the market in Asia Pacific.
Regional Insights:
For detailed understanding of market dynamics, On the basis of region the target market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. The market in North America is expected to account for major revenue share as compared to that of other regions. This can be attributed to the increasing prevalence of diabetes in the countries of the region. Also, the market in Europe is expected to account for second-highest revenue share in the global market, followed by the market in Asia Pacific.
|
Attribute |
Details |
|
Base year for estimation |
2020 |
|
Forecast period |
2020 – 2030 |
|
Market representation |
Revenue in USD Million & CAGR from 2020 – 2030 |
|
Market Segmentation |
By Product Type: Insulin Syringes, Insulin Pens, Insulin Pumps, and Insulin Jet Injectors By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies |
|
Regional scope |
North America - U.S., Canada Europe - UK, Germany, Spain, France, Italy, Russia, Rest of Europe Asia Pacific - Japan, India, China, South Korea, Australia, Rest of Asia-Pacific Latin America - Brazil, Mexico, Argentina, Rest of Latin America Middle East & Africa - South Africa, Saudi Arabia, UAE, Rest of Middle East & Africa |
|
Report coverage |
Revenue forecast, company share, competitive landscape, growth factors, and trends |
Detailed Segmentation:
Global Insulin Delivery Devices Market, By Product Type:
- Insulin Syringes
- Insulin Pens
- Insulin Pumps
- Insulin Jet Injectors
Global Insulin Delivery Devices Market, By Distribution Channel:
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
Global Insulin Delivery Devices Market, By Region:
o North America
-
- North America Insulin Delivery Devices Market, By Product Type
- North America Insulin Delivery Devices Market, By Distribution Channel
- North America Insulin Delivery Devices Market, By Country
- U.S.
- Canada
o Europe
-
- Europe Insulin Delivery Devices Market, By Product Type
- Europe Insulin Delivery Devices Market, By Distribution Channel
- Europe Insulin Delivery Devices Market, By Country
- Germany
- UK
- France
- Russia
- Italy
- Switzerland
- Sweden
- Rest of Europe
o Asia-Pacific
-
- Asia-Pacific Insulin Delivery Devices Market, By Product Type
- Asia-Pacific Insulin Delivery Devices Market, By Distribution Channel
- Asia-Pacific Insulin Delivery Devices Market, By Country
- China
- India
- Australia & New Zealand
- Japan
- South Korea
- Rest of Asia Pacific
o Latin America
-
- Latin America Insulin Delivery Devices Market, By Product Type
- Latin America Insulin Delivery Devices Market, By Distribution Channel
- Latin America Insulin Delivery Devices Market, By Country
- Brazil
- Mexico
- Argentina and Chile
- Rest of Latin America
o Middle East
-
- Middle East Insulin Delivery Devices Market, By Product Type
- Middle East Insulin Delivery Devices Market, By Distribution Channel
- Middle East Insulin Delivery Devices Market, By Country
- GCC
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East
o Africa
-
- Africa Insulin Delivery Devices Market, By Product Type
- Africa Insulin Delivery Devices Market, By Distribution Channel
- Africa Insulin Delivery Devices Market, By Country
- North Africa
- Central Africa
- South Africa
Global Insulin Delivery Devices Market Key Players
The Key players operating in the global insulin delivery devices market includes Novo Nordisk A/S,Sanofi, Medtronic Plc., Becton, Dickinson and Company, Eli Lilly and Company,Insulet Corporation, Abbott,Biocon Ltd., and F. Hoffmann-La Roche Ltd. Prominent players operating in the target market are focusing on the strategic partnerships as well as launching of the products in order to gain competitive edge in the target market.
Global Insulin Delivery Devices Market Company Profile
-
- Sanofi S.A.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Becton, Dickinson and Company
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Novo Nordisk A/S
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- F. Hoffmann-La Roche, Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Eli Lilly and Company
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Medtronic, Plc
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Ypsomed Holding AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Animas Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Insulet Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Sanofi S.A.
Global Insulin Delivery Devices Market Table of Contents
- Research Objective and Assumption
- Preface
- Research Objectives
- Study Scope
- Years Considered for the study
- Assumptions
- Abbreviations
- Research Methodology
- Research data
- Primary Data
- Primary Interviews
- Primary Breakdown
- Key data from Primary Sources
- Key Thickness Insights
- Secondary Data
- Major Secondary Sources
- Secondary Sources
- Market Estimation
- Top-Down Approach
- Approach for estimating Market Share by Top-Down Analysis (Supply Side)
- Bottom-Up Approach
- Approach for estimating market share by Bottom-up Analysis (Demand Side)
- Market Breakdown and Data Triangulation
- Research Assumptions
- Market Purview
- Executive Summary
- Key Findings—Global Outlook for Insulin Delivery Devices Strategies
- Key Questions this Study will Answer
- Market Snippet, By Product Type
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Opportunity Map Analysis
- Executive Summary—3 Big Predictions
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Market Trends
- DR Impact Analysis
- PEST Analysis
- Porter’s Five Forces Analysis
- Opportunity Orbit
- Market Investment Feasibility Index
- Macroeconomic Factor Analysis
- Market Dynamics
- Global Insulin Delivery Devices Market, By Product Type, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Insulin Syringes
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Insulin Pens
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Insulin Pumps
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Insulin Jet Injectors
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Insulin Delivery Devices Market, By Distribution Channel, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Segment Trends
- Hospital Pharmacies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Retail Pharmacies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Online Pharmacies
- Overview
- Market Size and Forecast (US$ Mn), and Y-o-Y Growth (%), 2020 – 2030
- Overview
- Global Insulin Delivery Devices Market, By Region, 2020 – 2030, (US$ Mn)
- Overview
- Market Value and Forecast (US$ Mn), and Share Analysis (%), 2020 – 2030
- Y-o-Y Growth Analysis (%), 2020 – 2030
- Regional Trends
- North America
- Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Distribution Channel, Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- U.S.
- Canada
- Europe
- Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Distribution Channel, Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- UK
- France
- Germany
- Russia
- Italy
- Rest of Europe
- Asia Pacific
- Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Distribution Channel, Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
- India
- Japan
- South Korea
- China
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Distribution Channel, Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
-
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- Market Size and Forecast (US$ Mn), By Product Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Distribution Channel, Type, 2020 – 2030
- Market Size and Forecast (US$ Mn), By Country, 2020 – 2030
-
- GCC
- Israel
- South Africa
- Rest of Middle East
- Overview
- Competitive Landscape
- Heat Map Analysis
- Market Presence and Specificity Analysis
- Company Profiles
-
- Sanofi S.A.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Becton, Dickinson and Company
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Novo Nordisk A/S
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- F. Hoffmann-La Roche, Ltd.
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Eli Lilly and Company
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Medtronic, Plc
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Ypsomed Holding AG
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Animas Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Insulet Corporation
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Highlights
- Strategies
- Sanofi S.A.
The Last Word
-
- Future Impact
- About Us
- Contact
FAQs
Global insulin delivery devices market is segmented on the basis of product type, distribution channels, and region.
The insulin deliver devices are gaining significant traction due to the increasing prevalence of diabetes.
North America is expected to account for major revenue share as compared to that of other regions.
The key players operating the Global Insulin Delivery Devices Market involves Institute Straumann AG, DENTSPLY Sirona Inc., Zimmer Biomet Holdings Inc., Danaher Corporation, AVINENT Implant System, Henry Schein Inc., OSSTEM Implant Co. Ltd., DIO Corporation, Merz Dental GmbH, and Bicon, LLC.